Illinois insurers may cover TMS for depression, but usually require prior authorisation and records of diagnosis, treatment history and unsuccessful medication trials.
TMS Insurance Coverage in Illinois: Preparing for Approval
Transcranial magnetic stimulation (TMS) is a non-surgical treatment most often considered for depression when other approaches have not brought enough improvement. It uses magnetic pulses applied to the scalp to stimulate areas of the brain involved in mood regulation. TMS was cleared by the FDA for major depressive disorder in 2008, and for depression with comorbid anxiety in 2021.
In Illinois, many people seek insurance cover before starting treatment because a standard TMS course usually involves weekday appointments over several weeks. Although insurers may cover TMS, approval is not automatic. Most plans require prior authorisation and supporting clinical records showing why TMS is medically appropriate.
Requirements can differ between insurers, plan types and individual policies. The process is usually managed by the prescribing psychiatrist and the TMS clinic, but patients can make it easier by gathering information early and understanding what may be requested.
What insurers commonly look for
Insurers usually assess whether TMS is medically necessary under the terms of a member’s plan. For depression, this often means confirming the diagnosis, the severity and persistence of symptoms, and previous treatment history.
A plan may ask for evidence in several areas.
Documented medication trials
Many insurers expect records showing that the person has tried antidepressant medication without enough benefit, or has been unable to tolerate it because of side effects. The exact number and type of medication trials required can vary.
Useful records may include:
- Names of current and previous psychiatric medicines
- Approximate dates each medicine was taken
- The dose reached, where known
- How long the medicine was taken
- Whether it was stopped, changed or continued
- The reason it did not provide sufficient improvement
- Any significant side effects or medical reasons for not continuing it
It is important for records to be accurate rather than simply extensive. A medication that was stopped after a very short period, or never taken at a therapeutic dose, may not be viewed in the same way as a properly documented treatment trial. Your psychiatrist can help explain the clinical context where a medicine could not be continued safely or reasonably.
Do not assume that a medication prescribed years ago will be visible to a new clinician or insurer. Pharmacy records, previous psychiatric notes and a written medication history can all help fill gaps.
Evidence of talking therapy or other care
Some plans may also ask about psychotherapy, such as cognitive behavioural therapy, counselling or other structured mental health treatment. They may want to know whether therapy has been tried, is ongoing, was not accessible, or was unsuitable for clinical reasons.
This does not mean everyone must have the same therapy history before TMS can be considered. Insurance criteria differ, and mental health care needs are individual. However, if you have attended therapy, it can be helpful to provide the name of the practice, approximate dates and, where appropriate, a summary of treatment.
Your TMS provider may also document other treatments that have been considered, including medication management, psychiatric review or more intensive services where relevant.
Diagnosis and symptom severity
Prior authorisation requests generally include a formal diagnosis and a clinical assessment of current symptoms. Insurers may look for evidence that depression remains significant despite previous treatment.
Clinicians commonly use standard symptom questionnaires to measure depression and track change over time. These may include a depression rating scale completed by the patient, clinician or both. The score is not the whole picture, but it gives the insurer a consistent way to see how symptoms affect daily life and whether treatment is helping.
Notes may describe difficulties such as:
- Low mood or loss of interest
- Changes in sleep, energy, appetite or concentration
- Reduced ability to work, study or manage responsibilities
- Social withdrawal
- Persistent symptoms despite treatment
- The impact of anxiety when it occurs alongside depression
Be open when completing questionnaires and speaking with your clinician. Understating symptoms can make it harder for the record to reflect what you are experiencing, while overstating them can affect the quality of care. The aim is an accurate clinical picture.
How prior authorisation usually works
Prior authorisation is the insurer’s review before it agrees to cover a planned treatment. It is not a guarantee that every session will be paid in every circumstance, but it is usually an important step before beginning a TMS course.
The process often follows a pattern:
- Clinical assessment: A psychiatrist or qualified mental health clinician evaluates whether TMS may be appropriate. This includes diagnosis, treatment history, current symptoms, medical history and safety screening.
- Benefits check: The clinic may contact the insurer to confirm whether TMS is a covered benefit under your plan and whether prior authorisation is required.
- Submission of records: The provider sends clinical notes, medication history, symptom measures and other requested documents to the insurer.
- Insurer review: The plan reviews the request against its own medical policy. It may approve treatment, deny the request, or ask for more information.
- Scheduling and treatment monitoring: If approved, the clinic can arrange treatment. During a standard course, symptom scores and clinical progress may be monitored. Some plans may require further review if more sessions are requested.
Timelines vary. It is sensible not to make assumptions about approval before the clinic has received confirmation from the insurer. Ask who will contact you with the decision and whether you will receive a written explanation.
If a request is denied, ask for the reason in writing. A denial may relate to missing records, an eligibility issue, a plan exclusion, or the insurer’s view that its criteria have not yet been met. Your clinician may be able to submit additional documentation or discuss whether an appeal is appropriate. The relevant plan documents and insurer correspondence are important at this stage.
Gathering your records before your consultation
Starting a folder before your TMS assessment can reduce delays. Electronic copies are often easiest to share securely, but paper records can still be useful.
Consider gathering:
- A list of psychiatric medicines you have tried
- Contact details for current and previous prescribers
- Pharmacy dispensing history, if available
- Recent psychiatric evaluations and progress notes
- Therapy attendance information or treatment summaries
- Previous depression questionnaire results, if you have them
- Hospital, emergency or intensive treatment records where relevant
- Your insurance card and plan information
- Any letters already received from your insurer about mental health cover
You do not need to interpret the records yourself. Bring what you can find and let the clinical team identify what is relevant to the authorisation request.
It can also help to write a short timeline in your own words. Include when symptoms began or worsened, treatments tried, what helped partly, what did not help enough, and how depression affects everyday activities. This can support a clearer discussion with the evaluating clinician.
Questions to ask your insurer and clinic
Before treatment begins, ask practical questions about both authorisation and your potential out-of-pocket responsibility. Coverage depends on your individual plan, including deductibles, co-payments, coinsurance, network rules and annual benefit arrangements.
Questions worth asking include:
- Is TMS covered under my specific Illinois health plan?
- Does my plan require prior authorisation?
- Does the clinic need to be in network?
- Which diagnosis and treatment-history criteria apply?
- Has authorisation been approved in writing?
- How many treatment sessions have been authorised?
- Could I have a deductible, co-payment or coinsurance to pay?
- What happens if the insurer requests more records?
- Who handles an appeal if the request is denied?
Avoid relying only on a general customer-service conversation as proof of cover. Ask for reference details from the call, and keep copies of authorisation letters and explanations of benefits.
Insurance plans commonly encountered in Illinois
Illinois residents may have cover through employer-sponsored plans, individual marketplace plans, Medicaid, Medicare, military-related cover or other arrangements. Requirements can differ even when two people have insurance from the same carrier.
Carriers commonly seen by Illinois TMS providers include Blue Cross Blue Shield of Illinois, Aetna, Cigna, UnitedHealthcare, Humana, Meridian / Illinois Medicaid, Medicare including Medicare Advantage plans, and TRICARE East.
Medicare Advantage plans are administered by private insurers and may use different processes from original Medicare. Medicaid managed-care arrangements can also have their own referral, network and authorisation rules. TRICARE members should confirm the applicable referral and authorisation pathway before arranging treatment.
A clinic’s staff may be familiar with common insurer processes, but only your insurer can confirm your own benefits and eligibility.
Getting help in Illinois
TMS Therapy Illinois lists 218 published clinics across the state, including listings in Chicago, Rockford, Peoria, Naperville, Orland Park, Arlington Heights, Decatur, Plainfield, Springfield, Libertyville, Buffalo Grove and St. Charles. Use the directory’s clinic listings to find local providers, the insurance guide to understand common cover questions, and the contact page for help using the directory.
This is educational information, not medical advice.
This page is informational and is not medical advice.